Embecta Corp Ownership
| EMBC Stock | USD 9.78 0.07 0.71% |
Embecta Stock Ownership Analysis
About 100.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 28th of May 2025. Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. operates independently of Becton, Dickinson and Company as of April 1, 2022. Embecta Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2000 people. To learn more about Embecta Corp call Devdatt Kurdikar at 862 401 0000 or check out https://www.embecta.com.Besides selling stocks to institutional investors, Embecta Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Embecta Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Embecta Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Embecta Corp Quarterly Liabilities And Stockholders Equity |
|
Embecta Corp Insider Trades History
Less than 1% of Embecta Corp are currently held by insiders. Unlike Embecta Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Embecta Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Embecta Corp's insider trades
Embecta Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Embecta Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Embecta Corp backward and forwards among themselves. Embecta Corp's institutional investor refers to the entity that pools money to purchase Embecta Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Millennium Management Llc | 2025-03-31 | 887 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 882.6 K | D. E. Shaw & Co Lp | 2025-03-31 | 831.6 K | Charles Schwab Investment Management Inc | 2025-03-31 | 735.1 K | Fmr Inc | 2025-03-31 | 729.6 K | Northern Trust Corp | 2025-03-31 | 683.2 K | Balyasny Asset Management Llc | 2025-03-31 | 681.7 K | Bank Of New York Mellon Corp | 2025-03-31 | 666.1 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 625.3 K | Blackrock Inc | 2025-03-31 | 9.2 M | Vanguard Group Inc | 2025-03-31 | 6.7 M |
Embecta Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Embecta Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Embecta Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Embecta Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Embecta Corp's latest congressional trading
Congressional trading in companies like Embecta Corp, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Embecta Corp by those in governmental positions are based on the same information available to the general public.
Embecta Corp Outstanding Bonds
Embecta Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Embecta Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Embecta bonds can be classified according to their maturity, which is the date when Embecta Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| EMERGENT BIOSOLUTIONS INC Corp BondUS29089QAC96 | View | |
| US29082KAA34 Corp BondUS29082KAA34 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| EMERA INC 675 Corp BondUS290876AD37 | View |
Embecta Corp Corporate Filings
| 18th of July 2025 Other Reports | ViewVerify | |
| 30th of May 2025 Other Reports | ViewVerify | |
F4 | 23rd of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Embecta Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Embecta Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Embecta Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Embecta Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Embecta Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Embecta Corp. If investors know Embecta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Embecta Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.20) | Dividend Share 0.6 | Earnings Share 0.89 | Revenue Per Share | Quarterly Revenue Growth (0.1) |
The market value of Embecta Corp is measured differently than its book value, which is the value of Embecta that is recorded on the company's balance sheet. Investors also form their own opinion of Embecta Corp's value that differs from its market value or its book value, called intrinsic value, which is Embecta Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Embecta Corp's market value can be influenced by many factors that don't directly affect Embecta Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Embecta Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Embecta Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.